Reference number
ISO/TR 12417-2:2022
© ISO 2024
Technical Report
ISO/TR 12417-2:2022
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
Edition 2
2022-07
Technical Report
Preview
недоступно на русском языке
Опубликовано (Версия 2, 2022)

ISO/TR 12417-2:2022

Язык
Формат
CHF 151
Пересчитать швейцарские франки (CHF) в ваша валюта

Тезис

This document provides region-specific information for:

—    local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;

—    changes related to the drug-containing part and how they are evaluated by different local regions.

For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

This document is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.

Общая информация

  • Текущий статус
     : Опубликовано
    Дата публикации
     : 2022-07
    Этап
    : Опубликование международного стандарта [60.60]
  • Версия
     : 2
  • Технический комитет :
    ISO/TC 150/SC 2
    ICS :
    11.040.40 
  • RSS обновления

Жизненный цикл

Появились вопросы?

Ознакомьтесь с FAQ

  2. Интернет-магазин
  3. Каталог стандартов
  4. МКС
  5. 11
  6. 11.040
  7. 11.040.40
  8. ISO/TR 12417-2:2022